April 19th 2024
Here is an update on the latest research and clinical management.
First In-Africa Clinical Trial of mRNA HIV Vaccine
May 18th 2022Today, the International AIDS Vaccine Initiative (IAVI) and Moderna announced they will soon launch a phase 1 clinical trial for their HIV vaccine candidate, administered with mRNA technology to develop broadly neutralizing antibodies.
Read More
All HIV Patients Should be Tested for Tuberculosis in High-Burden Areas
April 18th 2022The meta-analysis included 6 studies, of which 5 were conducted in sub-Saharan Africa, showed that the diagnostic accuracy for Xpert testing was similar to the former symptom screening and rapid test format.
Read More
Label Update for Cabotegravir and Rilpivirine Long-Acting HIV Treatment
March 24th 2022With FDA Approval, the oral lead-in for the cabotegravir and rilpivirine long-acting HIV treatment (Cabenuva) is now optional. Clinical trial data showed similar safety and efficacy profiles for initiating the therapy with or without the oral lead-in.
Read More
“Ramp Up the Resources”: Increased Effort and Funding Needed to End HIV
March 23rd 2022Congress’s spending bill allocated drastically less funding for HIV testing, prevention, and treatment than previously promised. Carl Schmid, executive director of the HIV+Hepatitis Policy Institute, explains why it is so vital to continue the fight against HIV.
Read More
Pre-Exposure Prophylaxis and Antiretroviral Therapy Set UK on Track to Eliminate HIV
February 16th 2022Due to policies rolling out HIV pre-exposure prophylaxis (PrEP) and commencing antiretroviral therapy at diagnosis, the UK is on track to eliminate new HIV infections among gay and bisexual men in approximately 25 years.
Read More